Fortrea Holdings Inc

Contributing Author

Recent Articles by Fortrea Holdings Inc

Jul-13	Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call FTRE GlobeNewswire
Jun-26	Fortrea Names Jason Knoblauch as Chief Financial Officer FTRE GlobeNewswire
Jun-10	Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) FTRE GlobeNewswire
Jun-02	Fortrea to Attend Jefferies Global Healthcare Conference FTRE GlobeNewswire
May-05	Fortrea Reports First Quarter 2026 Results FTRE +18.61% GlobeNewswire
Apr-21	Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call FTRE GlobeNewswire
Apr-07	Fortrea Unveils Fortrea Intelligent Technology to Help Sponsors and Sites Run Smarter, More Integrated Trials FTRE +5.55% GlobeNewswire
Mar-10	Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) FTRE -8.95% FTRE +5.25% GlobeNewswire
Feb-26	Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance FTRE GlobeNewswire
Feb-17	Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services FTRE GlobeNewswire
Jan-29	Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call FTRE GlobeNewswire
Jan-09	Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference FTRE FTRE +5.81% GlobeNewswire
Jan-06	Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference FTRE +5.54% GlobeNewswire
Dec-10	Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) FTRE +5.21% GlobeNewswire
Dec-04	SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery FTRE GlobeNewswire
Nov-25	Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences FTRE +6.95% GlobeNewswire
Nov-24	Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand FTRE +9.63% GlobeNewswire
Nov-17	Fortrea Appoints Agnieszka Gallagher as General Counsel FTRE -5.96% GlobeNewswire
Nov-05	Fortrea Reports Third Quarter 2025 Results FTRE +23.20% GlobeNewswire
Oct-20	Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt FTRE +10.26% GlobeNewswire
Oct-15	Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call FTRE GlobeNewswire
Sep-22	Fortrea Appoints William Sharbaugh to Board of Directors FTRE GlobeNewswire
Sep-12	Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) FTRE GlobeNewswire
Aug-06	Fortrea Reports Second Quarter 2025 Results FTRE GlobeNewswire
Aug-05	Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations FTRE GlobeNewswire
Aug-04	Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) FTRE +17.58% GlobeNewswire
Jul-16	Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call FTRE GlobeNewswire
Jun-24	Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin FTRE GlobeNewswire
Jun-12	Fortrea Adopts Limited-Duration Stockholder Rights Plan FTRE +15.47% GlobeNewswire
Jun-11	Fortrea Names Anshul Thakral Chief Executive Officer FTRE GlobeNewswire
Jun-03	Fortrea to Present at the Jefferies Global Healthcare Conference FTRE +12.11% FTRE +12.96% GlobeNewswire
May-12	Fortrea Reports First Quarter 2025 Results FTRE -15.61% GlobeNewswire
May-12	Fortrea Announces CEO Stepping Down FTRE -15.61% GlobeNewswire

Fortrea Holdings Inc

Recent Articles by Fortrea Holdings Inc

Upgrade your Finviz experience